Platinum currently approved compounds

Although thousands of cisplatin analogues have been synthesized and screened only about 28 platinum compounds have entered clinical trials as anticancer agents [6,9]. Of these only four are currently approved. Those approved are cisplatin (Scheme 8.22), carboplatin (Scheme 8.23), oxaliplatin (Scheme 8.24), andnedapla-tin (Scheme 8.25). Only the first two are commercially available for general use in the treatment of cancer. 

---